BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8197616)

  • 1. Evidence of alloreactive T suppressor cells in the maintenance phase of spontaneous tolerance after orthotopic liver transplantation in the rat.
    Knoop M; Pratt JR; Hutchinson IV
    Transplantation; 1994 May; 57(10):1512-5. PubMed ID: 8197616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Infectious tolerance" develops after the spontaneous acceptance of Lewis-to-Dark Agouti rat liver transplants.
    Kataoka M; Margenthaler JA; Ku G; Eilers M; Flye MW
    Surgery; 2003 Aug; 134(2):227-34. PubMed ID: 12947322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms maintaining antibody-induced enhancement of allografts. II. Mediation of specific suppression by short lived CD4+ T cells.
    Pearce NW; Spinelli A; Gurley KE; Dorsch SE; Hall BM
    J Immunol; 1989 Jul; 143(2):499-506. PubMed ID: 2472441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms in passive enhancement of cardiac and renal allografts by serum from liver-grafted rats.
    Yamaguchi A; Kamada N
    Immunology; 1991 Jan; 72(1):79-84. PubMed ID: 1825483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The persistence of regulatory cells developing after rat spontaneous liver acceptance.
    Asakura H; Takayashiki T; Ku G; Flye MW
    Surgery; 2005 Aug; 138(2):329-34. PubMed ID: 16153444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal deletion as the mechanism of abrogation of immunological memory following liver grafting in rats.
    Kamada N; Shinomiya T
    Immunology; 1985 May; 55(1):85-90. PubMed ID: 3888830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular basis of allograft rejection in vivo. V. Examination of the mechanisms responsible for the differing efficacy of monoclonal antibody to CD4+ T cell subsets in low- and high-responder rat strains.
    Ilano AL; McConnell MV; Gurley KE; Spinelli A; Pearce NW; Hall BM
    J Immunol; 1989 Nov; 143(9):2828-36. PubMed ID: 2572644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of serum class I antigen in allograft recipient rats--origin and control of serum class I antigen.
    Sumimoto R; Fukuda Y; Shinomiya T; Asahara T; Dohi K
    Hiroshima J Med Sci; 1998 Jun; 47(2):39-45. PubMed ID: 9674339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD25+CD4+ regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection.
    Steger U; Kingsley CI; Karim M; Bushell AR; Wood KJ
    Transplantation; 2006 Nov; 82(9):1202-9. PubMed ID: 17102772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4.
    Hall BM; Fava L; Chen J; Plain KM; Boyd RA; Spicer ST; Berger MF
    J Immunol; 1998 Nov; 161(10):5147-56. PubMed ID: 9820484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer of specific immunosuppression of graft rejection using lymph from tolerant liver-grafted rats.
    Kamada N
    Immunology; 1985 Jun; 55(2):241-7. PubMed ID: 3891594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
    J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rodent model of in utero chimeric tolerance induction.
    Yuh DD; Gandy KL; Hoyt G; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1997 Feb; 16(2):222-30. PubMed ID: 9059934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancement.
    Padberg WM; Lord RH; Kupiec-Weglinski JW; Williams JM; Di Stefano R; Thornburg LE; Araneda D; Strom TB; Tilney NL
    J Immunol; 1987 Sep; 139(6):1751-7. PubMed ID: 2957435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressor cells in transplantation tolerance. I. Analysis of the suppressor status of neonatally and adoptively tolerized rats.
    Dorsch S; Roser B
    Transplantation; 1982 May; 33(5):518-24. PubMed ID: 6211808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion induces blood donor-specific suppressor cells.
    Quigley RL; Wood KJ; Morris PJ
    J Immunol; 1989 Jan; 142(2):463-70. PubMed ID: 2521347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
    Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
    Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune mechanisms in organ allograft rejection. V. Pivotal role of the cytotoxic-suppressor T cell subset in the rejection of heart grafts bearing isolated class I disparities in the inbred rat.
    Lowry RP; Forbes RD; Blackburn JH; Marghesco DM
    Transplantation; 1985 Nov; 40(5):545-50. PubMed ID: 3904091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor cells and intrathymic inoculation of donor alloantigens in cardiac transplantation.
    Shen Z; Mohiuddin M; DiSesa VJ
    Ann Thorac Surg; 1995 Dec; 60(6):1683-5. PubMed ID: 8787463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.